Your browser doesn't support javascript.
loading
Structure-based identification of potential SARS-CoV-2 main protease inhibitors.
Khan, Shama; Fakhar, Zeynab; Hussain, Afzal; Ahmad, Aijaz; Jairajpuri, Deeba Shamim; Alajmi, Mohamed F; Hassan, Md Imtaiyaz.
Afiliação
  • Khan S; Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Fakhar Z; Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Johannesburg, South Africa.
  • Hussain A; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
  • Ahmad A; Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Jairajpuri DS; National Health Laboratory Service, Infection Control, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Alajmi MF; Department of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.
  • Hassan MI; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
J Biomol Struct Dyn ; 40(8): 3595-3608, 2022 05.
Article em En | MEDLINE | ID: mdl-33210561

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article